PedAM
Pediatric Disease Annotations & Medicines
| Disease | artery disease |
| Phenotype | C0018801|heart failure |
| Sentences | 48 |
| PubMedID- 21110840 | Exclusion criteria included clinically overt heart failure, a history of coronary artery disease and/or previous myocardial infarction, recognized valvular heart disease, or primary cardiomyopathies. |
| PubMedID- 24579542 | Coronary artery disease with heart failure was present in 14 patients. |
| PubMedID- 23537805 | Anxiety and depression were identified using the cutoff scores shown to have optimal sensitivity and specificity for detecting anxiety disorders and clinical depression (anxiety cases, hads‐a scores ≥8; depression cases, hads ‐d scores ≥8).32 in the originally planned model, age, congestive heart failure (chf), presence of 3‐vessel coronary artery disease, lvef, and renal disease were evaluated with anxiety and/or depression, both separately and together. |
| PubMedID- 20805280 | Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study. |
| PubMedID- 25369444 | Objectives: this study aimed to (a) investigate whether atorvastatin reload protects against acute heart failure (ahf) in patients with stable coronary artery disease (cad) undergoing noncardiac emergency surgery and decreases the incidence of major adverse cardiac events (mace) during hospitalization and (b) elucidate its possible mechanism of action. |
| PubMedID- 20234351 | The benefits of statin treatment seem to mostly result from their ability to halt disease progression in heart failure, particularly in patients with coronary artery disease. |
| PubMedID- 24424466 | Left ventricular biopsies from patients with end-stage heart failure due to coronary artery disease (cad) or dilated cardiomyopathy were investigated for the content of ra metabolites using liquid chromatography mass spectrometry (lc-ms/ms), and compared with healthy donors. |
| PubMedID- 21721426 | Background: diagnosis of coronary artery disease in patients with heart failure with systolic dysfunction usually requires coronary angiography. |
| PubMedID- 23891428 | A simple validated clinical tool to predict the absence of coronary artery disease in patients with systolic heart failure of unclear etiology. |
| PubMedID- 26423730 | Circulating thrombospondine-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease. |
| PubMedID- 23837998 | Ppgl should be suspected in patients with acute heart failure without evidence of valvular or coronary artery disease. |
| PubMedID- 25822806 | However, estimating the presence or absence of coronary artery disease in patients with heart failure is sometimes difficult without coronary imaging. |
| PubMedID- 25440594 | Several studies have shown that statins, having an important effect in the prevention of acute coronary syndromes, are also able to prevent heart failure (hf) in patients with coronary artery disease. |
| PubMedID- 24561111 | Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy. |
| PubMedID- 24656111 | The role of coronary artery disease in heart failure. |
| PubMedID- 23016898 | Several studies have shown that statins, having an important effect in the prevention of acute coronary syndromes, are also able to prevent heart failure (hf) in patients with coronary artery disease. |
| PubMedID- 25176136 | Methods: we conducted a randomized, double-blind, placebo-controlled trial of ivabradine, added to standard background therapy, in 19,102 patients who had both stable coronary artery disease without clinical heart failure and a heart rate of 70 beats per minute or more (including 12,049 patients with activity-limiting angina [class >/=ii on the canadian cardiovascular society scale, which ranges from i to iv, with higher classes indicating greater limitations on physical activity owing to angina]). |
| PubMedID- 25864342 | [clinical and pathogenetic features of inflammatory and atrophic changes in the gastroduodenal zone in patients with varying severity of chronic heart failure associated with coronary artery disease]. |
| PubMedID- 23540585 | heart failure therapy in patients with coronary artery disease. |
| PubMedID- 25371662 | Ppar gamma expression levels during development of heart failure in patients with coronary artery disease after coronary artery bypass-grafting. |
| PubMedID- 23865420 | One patient (asa iii) who had congestive heart failure (chf) due to coronary artery disease and arrhythmias before, and whose hr was regulated with an automated implanted cardioverter-defibrillator went into severe hypotension at the end of his surgery and required immediate pharmacologic resuscitation and chest compressions. |
| PubMedID- 24983270 | Methods: heart failure patients with multivessel coronary artery disease undergoing first-time, isolated cabg between 1992 and 2011 were included in this study. |
| PubMedID- 24693440 | It is more common in men, coronary artery disease, and those with congestive heart failure. |
| PubMedID- 21156659 | Aims: revascularization is frequently advocated to improve ventricular function and prognosis for patients with heart failure due to coronary artery disease, especially when there is evidence of extensive myocardial viability. |
| PubMedID- 21382729 | Serum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease. |
| PubMedID- 20974768 | Sudden cardiac and arrhythmic death (scd) account for approximately 50% of the mortality in patients with left ventricular dysfunction.1 life-threatening ventricular arrhythmias are involved in the majority of scd occurrences.2 randomized clinical trials have shown that the implantable cardioverter-defibrillator (icd) is the most effective therapy currently available to prevent scd by terminating ventricular arrhythmias.3–6 therefore, the icd has become the standard therapy for primary and secondary prevention of scd in patients with left ventricular dysfunction.7,8 the addition of cardiac resynchronization therapy (crt) to device therapy created not only possibilities to improve cardiac function in subgroups, but also influenced the outcome with respect to morbidity and mortality.9,10 in contrast, concerns were raised on the magnitude of the effectiveness of icd therapy certainly in this era when the majority of infarction patients receive primary coronary intervention in a reasonable time frame.11 some complications became more evident in the past few years, and co-morbidity became considered as limitation as it is associated with a less favourable outcome.12,13 given these recent concerns about icd therapy, we performed a systematic review and meta-analysis of randomized trials of primary prevention of scd in patients with heart failure due to coronary artery disease (cad) or dilated cardiomyopathy (dcm), which constitute the largest two subgroups of potential icd recipients. |
| PubMedID- 22968743 | Aims: data on the prognosis of heart failure (hf) patients with coronary artery disease (cad) have been conflicting. |
| PubMedID- 24766981 | Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease. |
| PubMedID- 24768876 | Objectives: this study investigated the characteristics, evaluation, prognostic impact, and treatment of coronary artery disease (cad) in patients with heart failure and preserved ejection fraction (hfpef). |
| PubMedID- 20625213 | Background: although left ventricular (lv) diastolic dysfunction is associated with increased risk for incident heart failure in patients with coronary artery disease (cad), no specific treatment for diastolic abnormalities has been established. |
| PubMedID- 25608461 | Type d personality, mental distress, social support and health-related quality of life in coronary artery disease patients with heart failure: a longitudinal observational study. |
| PubMedID- 24444446 | Association of casq2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease. |
| PubMedID- 21515837 | It is known that type 2 diabetes is an independent risk factor for heart failure independently of coronary artery disease or hypertension (6). |
| PubMedID- 21450621 | Aim: this study evaluated amino-terminal pro b-natriuretic peptide (nt-probnp) as a risk marker in primary care patients with hypertension, diabetes, clinically suspected heart failure (hf), history of coronary artery disease or myocardial infarction. |
| PubMedID- 22639341 | Furthermore, diabetes can be associated with heart failure, independent of underlying coronary artery disease, hypertension, or valve abnormalities. |
| PubMedID- 23777457 | On the other hand, patients with chronic heart failure due to coronary artery disease are more likely to have abnormalities in glucose metabolism than are patients with congestive heart failure (chf) due to idiopathic dilated cardiomyopathy [19]. |
| PubMedID- 23335377 | Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease. |
| PubMedID- 23448803 | Age 27.5 (4.8) years; 2.7% hypertensive; 0% coronary artery disease; 0.5% with heart failure; and 2.8% diabetes mellitus). |
| PubMedID- 21069458 | The prevalence of heart failure due to coronary artery disease continues to increase, and it portends a worse prognosis than non-ischemic cardiomyopathy. |
| PubMedID- 24172076 | Background: the detection of significant coronary artery disease (cad) in patients with heart failure (hf) from left ventricular (lv) systolic dysfunction is crucial. |
| PubMedID- 22011801 | Conclusion: the prevalence of asymptomatic coronary artery disease in patients with severe heart failure due to chagas disease is low and among the risk factors for coronary heart disease, smoking was the most prevalent. |
| PubMedID- 25068953 | A diagnosis of acute heart failure due to coronary artery disease and hypertensive heart disease was made. |
| PubMedID- 23243502 | The evidence indicates a strong association between ad and cardiovascular risk factors, including apoe(4), atrial fibrillation, thrombotic events, hypertension, hypotension, heart failure, high serum markers of inflammation, coronary artery disease, low cardiac index, and valvular pathology. |
| PubMedID- 20196785 | Heart diseases, such as pathologic hypertrophy, dilated cardiomyopathy and coronary artery disease, eventually lead to heart failure. |
| PubMedID- 20953615 | Although mildly reduced renal function is associated with increased risk for heart failure in patients with coronary artery disease (cad), mechanisms underlying the association remain unclear. |
| PubMedID- 20577643 | Causes of functional impairment include microcirculatory disturbances, hypertensive heart disease, congestive heart failure due to coronary artery disease, hypertrophic obstructive and non obstructive cardiomyopathy and dilative cardiomyopathy. |
| PubMedID- 24503058 | It also includes nine mutually exclusive groups of patients: st elevation myocardial infarction, non-st elevation acute coronary syndrome, secondary prevention after myocardial infarction, secondary prevention after revascularisation, chronic stable coronary artery disease, patients with severe heart failure requiring at least one admission to hospital, heart failure patients treated only in the community, and two primary pharmacological prevention groups of patients receiving antihypertensive drugs or statins. |
| PubMedID- 25451487 | Methods: of 1000 patients in the surgical treatment for ischemic heart failure with coronary artery disease, left ventricular ejection fraction 35% or less, and anterior dysfunction, who were randomized to undergo coronary artery bypass grafting or coronary artery bypass grafting + surgical ventricular reconstruction, baseline right ventricular function could be assessed by echocardiography in 866 patients. |
Page: 1